Protein Sequencing Market Size, Share, Growth Analysis, By Product (Protein Sequencing Products, Protein Sequencing Services), By Application (Biomarker Discovery, Protein Engineering Studies), By End-User (Pharmaceutical & Biotechnology Companies, Research Centers), By Region - Industry Forecast 2025-2032

Global Protein Sequencing Market size was valued at USD 1.02 billion in 2022 and is poised to grow from USD 1.06 billion in 2023 to USD 1.41 billion by 2031, growing at a CAGR of 3.7% during the forecast period (2024-2031).

Global Protein Sequencing Market is highly competitive and somewhat fragmented. To maintain a competitive edge, the major industry participants are continually implementing various growth strategies. Innovations, mergers and acquisitions, collaborations and partnerships are adopted by these players to thrive in the competitive market. In order to provide industries with the most effective and economical solutions, the major market players are also continually concentrating on R&D. 'Thermo Fisher Scientific Inc. (USA) ', 'Agilent Technologies, Inc. (USA) ', 'Bioinformatics Solutions Inc. (Canada) ', 'Shimadzu Corporation (Japan) ', 'Waters Corporation (USA) ', 'Bruker Corporation (USA) ', 'Danaher Corporation (USA) ', 'PerkinElmer, Inc. (USA) ', 'Charles River Laboratories International, Inc. (USA) ', 'QIAGEN N.V. (Netherlands) ', 'Merck KGaA (Germany) ', 'GenScript Biotech Corporation (China) ', 'Creative Proteomics (USA) ', 'Bio-Rad Laboratories, Inc. (USA) ', 'Promega Corporation (USA) ', 'Pacific Biosciences of California, Inc. (USA) ', 'Oxford Nanopore Technologies Ltd. (UK) ', 'Illumina, Inc. (USA) ', 'Becton, Dickinson and Company (USA) ', 'Eurofins Scientific (Luxembourg) '

The factor projected to propel the expansion of the target market over the forecast period is improvements in clinical mass spectrometry and analytical procedures. In addition, growing financial support from the public and private sectors for proteome research is a key dynamic anticipated to fuel the development of the target market throughout the forecast period.

Protein engineering is the manipulation of protein structures to achieve desired properties or the synthesis of proteins with specific structures. Bioformulations, such as antibodies, nucleic acid products, and vaccines, account for the vast majority of therapeutic drugs on the market today. The incorporation of unnatural amino acids is a field in protein engineering that companies are focusing on for the site-specific conjugation of functional moieties to biopharmaceuticals (uAA). Rapid advances in post-translational engineering and strain development to produce better-defined products should result in faster biopharmaceutical approval.

North America held the largest global protein sequencing market share and is anticipated to continue dominating over the projection period. The target market in the region is anticipated to expand as a result of rising funding for proteome research from public and private organisations, as well as the presence of significant important players in nations like the US and Canada. In the upcoming years, it is predicted that the Asia Pacific market will represent a sizeable portion of the market's value. During the forecast period, China is anticipated to see the fastest growth rate. Rising government initiatives and investments in life science research and development in nations like India and Japan are anticipated to assist the expansion of the target market. Europe Protein Sequencing Market is predicted to experience moderate revenue growth over the forecast period.